Dominic Borie is the founder of Kyverna Therapeutics. Kyverna Therapeutics has raised $170M in total funding. Latest round: Series B.
Dominic Borie, MD, PhD, is the CEO of Kyverna Therapeutics, a clinical-stage cell therapy company focused on engineering treatments for autoimmune and inflammatory diseases. He was previously Chief Medical Officer and Head of Research & Development at Cue Biopharma.
Full founder directory · Investor directory · Company funding database · Fundraising library